|
|
Volumn 60, Issue 13-14, 1997, Pages 977-984
|
|
In vivo consequences of M1-receptor activation by talsaclidine
a
|
|
Author keywords
adrenal medulla; Alzheimer's disease; sympathetic nervous system; talsaclidine
|
|
Indexed keywords
2 ETHYL 8 METHYL 2,8 DIAZASPIRO[4.5]DECANE 1,3 DIONE;
[4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM;
ACECLIDINE;
ADRENALIN;
ARECOLINE;
ATROPINE;
CARBACHOL;
CATECHOLAMINE;
DOPAMINE;
HEXAMETHONIUM;
MUSCARINIC M1 RECEPTOR;
MUSCARINIC M1 RECEPTOR AGONIST;
MUSCARINIC M2 RECEPTOR;
MUSCARINIC M3 RECEPTOR;
NORADRENALIN;
PARTIAL AGONIST;
PHENTOLAMINE;
PIRENZEPINE;
RECEPTOR SUBTYPE;
TALSACLIDINE;
THIOPILOCARPINE;
TOLIPROLOL;
UNCLASSIFIED DRUG;
MUSCARINIC AGENT;
MUSCARINIC RECEPTOR;
ADRENAL MEDULLA;
ADRENERGIC SYSTEM;
ANESTHESIA;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
BLOOD BRAIN BARRIER;
CATECHOLAMINE BLOOD LEVEL;
CONFERENCE PAPER;
CONTROLLED STUDY;
DOG;
DRUG ANTAGONISM;
FEMALE;
GUINEA PIG;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY VASCULAR RESISTANCE;
MALE;
NONHUMAN;
ANIMAL;
ARTICLE;
BLOOD;
BLOOD PRESSURE;
DRUG EFFECT;
HEART RATE;
ANIMALS;
BLOOD PRESSURE;
CATECHOLAMINES;
DOGS;
FEMALE;
HEART RATE;
INFUSIONS, INTRAVENOUS;
MALE;
MUSCARINIC AGONISTS;
RECEPTOR, MUSCARINIC M1;
RECEPTORS, MUSCARINIC;
|
|
EID: 0030609970
PISSN: 00243205
EISSN: None
Source Type: Journal
DOI: 10.1016/S0024-3205(97)00037-4 Document Type: Conference Paper |
|
Times cited : (12)
|
|
References (9)
|
